Clinical Trials Directory

Trials / Completed

CompletedNCT03988777

Magnetic Seed Localisation for Nonpalpable Breast Lesions

Magnetic Seed Localisation for Nonpalpable Breast Lesions: a Combined Retrospective and Prospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
192 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Screening programs and advances in imaging have led to more breast lesions being diagnosed at an impalpable stage. Multiple localisation techniques for nonpalpable breast lesions have been developed during the past decades. Specifically, several alternatives to the golden standard hooked-wire technique have become available, of which magnetic seed localisation is one of the newest approaches. Since September 2018, Magseed® localisation is the standard of care for localising impalpable breast lesions in UZ Leuven. In this study, the oncological safety, the clinical safety and surgeon satisfaction of Magseed® localisation will be assessed and retrospectively compared to hooked-wire localisation.

Conditions

Interventions

TypeNameDescription
DEVICEPreoperative localisation techniqueImpalpable breast lesions are preoperatively localised, either with hooked-wire (retrospective study) or Magseed (prospective study)

Timeline

Start date
2018-09-10
Primary completion
2019-03-29
Completion
2019-05-23
First posted
2019-06-17
Last updated
2019-06-17

Locations

1 site across 1 country: Belgium

Regulatory

Source: ClinicalTrials.gov record NCT03988777. Inclusion in this directory is not an endorsement.